| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/ARCHINTE.168.15.1678 |
| P698 | PubMed publication ID | 18695082 |
| P50 | author | Georg Heinze | Q57012893 |
| P2093 | author name string | Oswald Wagner | |
| Erich Minar | |||
| Sabine Eichinger | |||
| Gregor Hron | |||
| Paul A Kyrle | |||
| Mirko Hirschl | |||
| Christine Bialonczyk | |||
| P433 | issue | 15 | |
| P921 | main subject | obesity | Q12174 |
| venous thromboembolism | Q9397786 | ||
| P304 | page(s) | 1678-1683 | |
| P577 | publication date | 2008-08-01 | |
| P1433 | published in | JAMA Internal Medicine | Q177428 |
| P1476 | title | Overweight, obesity, and the risk of recurrent venous thromboembolism | |
| P478 | volume | 168 |
| Q83279283 | 4G/5G polymorphism modulates PAI-1 circulating levels in obese women |
| Q37774237 | Acute pulmonary embolism. Part 1: epidemiology and diagnosis |
| Q92632109 | Age Distribution, Comorbidities and Risk Factors for Thrombosis in Prader-Willi Syndrome |
| Q51833118 | Analysis of endothelial protein C receptor gene and metabolic profile in Prader-Willi syndrome and obese subjects. |
| Q26796430 | Assessing the risk of recurrent venous thromboembolism--a practical approach |
| Q91795686 | Bariatric surgery in morbidly obese individuals affects plasma levels of protein C and thrombomodulin |
| Q33951474 | Body mass index and risk of left atrial thrombus in patients with atrial fibrillation |
| Q93171260 | Case series: Portomesenteric venous thrombosis complicating laparoscopic bariatric procedures |
| Q50098106 | Catheter-directed, ultrasound-facilitated fibrinolysis in obese patients with massive and submassive pulmonary embolism |
| Q38857017 | Characteristics and Impacts of Venous Thromboembolism in Patients with Hepatocellular Carcinoma |
| Q44926539 | Clinical markers of the hypercoagulable state by rotational thrombelastometry in obese patients submitted to bariatric surgery |
| Q38176917 | Comparison of heparin dosing based on actual body weight in non-obese, obese and morbidly obese critically ill patients |
| Q38046777 | Comparison of initial warfarin response in obese patients versus non-obese patients |
| Q34798985 | Dosing of unfractionated heparin in obese patients with venous thromboembolism |
| Q36126175 | Educational Level, Anticoagulation Quality, and Clinical Outcomes in Elderly Patients with Acute Venous Thromboembolism: A Prospective Cohort Study |
| Q37353441 | Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects |
| Q92323366 | Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data |
| Q53101380 | Efficacy and safety of high-dose thromboprophylaxis in morbidly obese inpatients. |
| Q37370722 | Epidemiology of recurrent venous thrombosis |
| Q41667853 | Epidemiology of venous thromboembolism |
| Q90313183 | Extended anticoagulation after venous thromboembolism: should it be done? |
| Q28078989 | Guidance for the treatment of deep vein thrombosis and pulmonary embolism |
| Q84128615 | Impact of a pharmacotherapeutic programme on control and safety of long-term anticoagulation treatment: a controlled follow-up study in Spain |
| Q92578954 | Incidence and Risk Factors of Recurrent Venous Thromboembolism after Pulmonary Embolism |
| Q40434255 | Influence of Body Mass Index on Venous Thrombotic Complications of Liver Transplants |
| Q88009010 | Interaction of a genetic risk score with physical activity, physical inactivity, and body mass index in relation to venous thromboembolism risk |
| Q57616460 | Longer legs are associated with greater risk of incident venous thromboembolism independent of total body height. The Longitudinal Study of Thromboembolism Etiology (LITE) |
| Q26749273 | Management of Venous Thromboembolisms: Part I. The Consensus for Deep Vein Thrombosis |
| Q37792663 | Management of deep vein thrombosis to reduce the incidence of post-thrombotic syndrome |
| Q89468101 | Mechanisms and mitigating factors for venous thromboembolism in chronic kidney disease: the REGARDS study |
| Q92518274 | Metabolic syndrome increases risk of venous thromboembolism recurrence after acute deep vein thrombosis |
| Q36327186 | Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events? |
| Q47847424 | Obesity Paradox in Patients With Deep Venous Thrombosis. |
| Q57021532 | Obesity and Pulmonary Hypertension |
| Q34786675 | Obesity and clotting: Body mass index independently contributes to hypercoagulability after injury |
| Q82710017 | Obesity and thrombotic risk |
| Q41702785 | Obesity is not associated with recurrent venous thromboembolism in elderly patients: Results from the prospective SWITCO65+ cohort study. |
| Q34781477 | Optimal duration of anticoagulation after venous thromboembolism |
| Q35210139 | Optimal duration of anticoagulation in patients with venous thromboembolism. |
| Q33399576 | Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines |
| Q39627365 | Persistent neutrophilia is a marker for an increased risk of venous thrombosis. |
| Q38062477 | Pharmacologic prevention of venous thromboembolism in obese patients |
| Q26830471 | Physiological and management implications of obesity in critical illness |
| Q42186530 | Portal vein thrombosis following laparoscopic sleeve gastrectomy for morbid obesity |
| Q51204068 | Portomesenteric vein thrombosis after laparoscopic sleeve gastrectomy for morbid obesity. |
| Q38365637 | Predicting the risk of recurrent venous thromboembolism (VTE). |
| Q26865059 | Predicting the risk of venous thromboembolism recurrence |
| Q90475553 | Predictors of Recurrent Venous Thromboembolism after Pulmonary Embolism in Korea |
| Q35920759 | Predictors of venous thromboembolism recurrence, adjusted for treatments and interim exposures: a population-based case-cohort study |
| Q35633708 | Prevention of venous thromboembolism in obesity |
| Q92759954 | Prognostic characteristics and body mass index in patients with pulmonary embolism: does size matter? |
| Q35973634 | Quantification of hypercoagulable state after blunt trauma: microparticle and thrombin generation are increased relative to injury severity, while standard markers are not. |
| Q30317272 | Recurrent cerebral venous sinus thrombosis in a patient with increased factor VIII activity, increased lipoprotein (a) level and leukocytosis: a case report |
| Q26826847 | Recurrent venous thromboembolism: what is the risk and how to prevent it |
| Q90480333 | Reduced dosing of enoxaparin for venous thromboembolism in overweight and obese adolescents: a single institution retrospective review |
| Q34153343 | Risk assessment for recurrent venous thrombosis |
| Q36698661 | Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type |
| Q46329568 | Special Populations Critical Care Considerations of the Morbidly Obese Pregnant Patient |
| Q41877008 | Successful pulmonary endarterectomy in a patient with klinefelter syndrome |
| Q64241228 | The Crashing Obese Patient |
| Q35904699 | The effects of obesity on venous thromboembolism: A review |
| Q28067893 | The epidemiology of venous thromboembolism |
| Q37523338 | The role of ethnicity, age and gender in venous thromboembolism |
| Q38864710 | Thrombin generation profiles as predictors of symptomatic venous thromboembolism after trauma: A prospective cohort study. |
| Q39027731 | Thrombosis in the setting of obesity or inflammatory bowel disease. |
| Q35419411 | Thrombotic events in metastatic colorectal cancer patients treated with leucovorin, fluorouracil and irinotican (FOLFIRI) plus bevacizumab |
| Q34694544 | Treatment options for venous thromboembolism: lessons learnt from clinical trials |
| Q37802497 | Venous Thromboembolic Disease and Hematologic Considerations in Obesity |
| Q55113169 | Venous Thromboembolism Risk and Adequacy of Prophylaxis in High Risk Pregnancy in the Arabian Gulf. |
| Q50110987 | Venous Thromboembolism Within Professional American Sport Leagues |
| Q37843743 | Which patients with unprovoked VTE should receive extended anticoagulation? the minority |
Search more.